Linear IgA bullous dermatosis: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Add image
+Images
Line 2: Line 2:
| name = {{PAGENAME}}
| name = {{PAGENAME}}
| synonyms =
| synonyms =
| image = IgA bullous dermatosis.jpg
| image = Linear IgA bullous dermatosis.jpg
| alt =
| alt =
| caption = a Widespread vesiculobullous eruption on the lower limbs with elements in a “string of pearls” arrangement; <br>(b) targetoid vesicular lesions on erythematous skin involving the dorsa of the hands; <br>(c) blisters with a “string of pearls” configuration and crusts in the perioral area;<br> (d) erythematous, vesicular lesions partially eroded on the posterior aspects of both thighs;<br> (e) vesicles involving the vulvar area in a child.<ref>{{cite journal|last1=Genovese|first1=Giovanni|last2=Venegoni|first2=Luigia|last3=Fanoni|first3=Daniele|last4=Muratori|first4=Simona|last5=Berti|first5=Emilio|last6=Marzano|first6=Angelo Valerio|title=Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients|journal=Orphanet Journal of Rare Diseases|volume=14|issue=1|year=2019|issn=1750-1172|doi=10.1186/s13023-019-1089-2}}
| caption =
*"This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)"</ref>
| pronounce =
| pronounce =
| field =
| field =
Line 27: Line 28:
* ''Childhood linear IgA disease'' (also known as "Chronic bullous disease of childhood") is an acquired, self-limited bullous disease that may begin by the time the patient is age 2 to 3 and usually remits by age 13.<ref name="Andrews"/>
* ''Childhood linear IgA disease'' (also known as "Chronic bullous disease of childhood") is an acquired, self-limited bullous disease that may begin by the time the patient is age 2 to 3 and usually remits by age 13.<ref name="Andrews"/>


<gallery>
File:Micrograph of linear IgA bullous dermatosis.jpg|[[Micrograph]]: Subepidermal blister formation and neutrophils
File:IgA bullous dermatosis.jpg
</gallery>
==See also==
==See also==
* [[Skin lesion]]
* [[Skin lesion]]

Revision as of 11:22, 6 November 2019

Linear IgA bullous dermatosis
a Widespread vesiculobullous eruption on the lower limbs with elements in a “string of pearls” arrangement;
(b) targetoid vesicular lesions on erythematous skin involving the dorsa of the hands;
(c) blisters with a “string of pearls” configuration and crusts in the perioral area;
(d) erythematous, vesicular lesions partially eroded on the posterior aspects of both thighs;
(e) vesicles involving the vulvar area in a child.[1]
SpecialtyImmunology, dermatology Edit this on Wikidata

Linear IgA bullous dermatosis is a rare immune-mediated blistering skin disease frequently associated with medication exposure, especially vancomycin, with men and women being equally affected.[2]: 135  It was first described by Tadeusz Chorzelski in 1979 and may be divided into two types:[3]: 587 

  • Adult linear IgA disease is an acquired, autoimmune blistering disease that may present with a clinical pattern of vesicles indistinguishable from dermatitis herpetiformis, or with vesicles and bullae in a bullous pemphigoid-like appearance.[2] This disease can often be difficult to treat even with usually effective medications such as rituximab.[4]
  • Childhood linear IgA disease (also known as "Chronic bullous disease of childhood") is an acquired, self-limited bullous disease that may begin by the time the patient is age 2 to 3 and usually remits by age 13.[2]

See also

References

  1. ^ Genovese, Giovanni; Venegoni, Luigia; Fanoni, Daniele; Muratori, Simona; Berti, Emilio; Marzano, Angelo Valerio (2019). "Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients". Orphanet Journal of Rare Diseases. 14 (1). doi:10.1186/s13023-019-1089-2. ISSN 1750-1172.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  2. ^ a b c James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
  3. ^ Freedberg, et al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0-07-138076-0.
  4. ^ He Y, Shimoda M, Ono Y, Villalobos IB, Mitra A, Konia T, Grando SA, Zone JJ, Maverakis E (2015). "Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab". JAMA Dermatol. 151 (6): 646–50. doi:10.1001/jamadermatol.2015.59. PMID 25901938.

External links